On a mission for mental health
Mental disorders have a strong impact on humanity and society, without sparing the younger generations. The lack of knowledge inhibits the emergence of ways in which to improve life trajectories. The mission of the Synapsy Centre for Neuroscience and Mental Health Research is to solve this through research, training and knowledge transfer.
Synapsy Center Progress Reports
We are launching: the "Synapsy Center Progress Reports” – this will be an opportunity for two research groups (clinical and pre-clinical) to present their research on a given topic. One or two person(s) per group will present their current work with the goal of fostering interactions between Centre groups. All meetings are open to All within the Centre and you are strongly encouraged to participate.
Inauguration of the "NeuroNA Human Cellular Neuroscience Platform"
We are delighted to announce the inauguration our new NeuroNA Foundation Human Cellular Neuroscience platform. This state-of-the-art platform offers an unprecedented tool for the study the human brain at the cellular level and to unravel mechanisms that lead to neuropsychiatric diseases such as autism, schizophrenia and depression.
Semaine du cerveau
Juste une illusion? Just an illusion? The International Brain Week is organised every year in March by the Geneva University Neurocenter. Lectures for the general public are offered every evening of the week, at 19:00 at Uni Dufour (24 rue du Général-Dufour). Admission is free and no registration is required. Full programme and information: https://semaineducerveau.ch/
Leenaards Foundation 2023 Science Prize – Cerebellar stimulation can address the negative symptoms of schizophrenia
Lausanne, 21 February 2023. The Leenaards Foundation will hand out its annual Science Prize, together with over CHF 1.5 million in award money, to three research groups in the Lake Geneva region at a ceremony on 23 March. The research groups are headed by Dr. Sylvain Meylan, who is addressing the problem of antibiotic resistance with a new antibiotic-treatment strategy based on sugar; Dr. Indrit Bègue, who is investigating cerebellar stimulation as a method for alleviating certain symptoms of schizophrenia, such as apathy; and Prof. Julien Vaucher, who is working to better understand the causal link between genetic markers and cardiovascular disease.